Biograil ApS: Financial statements 2024
CVR: 40666699
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Biograil ApS (CVR 40666699) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,816,978 and a net result of DKK -17,084,308 compared with DKK -34,799,433 the year before. Equity in the 2024 report amounted to DKK 18,779,473. The solvency ratio was 25%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 4,816,978
- Profit/Loss
- DKK -17,084,308
- Equity
- DKK 18,779,473
- Total Assets
- DKK 75,079,921
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.8 mio. | -17.1 mio. | 18.8 mio. | 18 |
| 2023 | - | -16.7 mio. | -34.8 mio. | 10 mio. | 14 |
| 2022 | - | 26.3 mio. | 12.9 mio. | 44.8 mio. | 6 |
| 2021 | - | -5.4 mio. | -7.9 mio. | 31.9 mio. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biograil ApS has published its annual report for 2023. Gross profit came to DKK -16,707,823, and the net result was DKK -34,799,433.
About Biograil ApS
Biograil ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Karsten Lindhardt. The board consists of John Michael Barberich (chair), Karsten Lindhardt, Lars Hellerung Christiansen and Robert Samuel. The company's owners include Lindhardt Holdings ApS, MTI Biograil Invest A/S and Eli Lilly and Company. The company has 23 employees (2026). In 2025, the company reported a gross profit of DKK -13,192,351 and a net result of DKK -22,366,605 compared with DKK -17,084,308 the year before. Equity in the 2025 report amounted to DKK 102,217,548.